Verastem, Inc. (VSTM) shareholders
Close on Nov 17, 2026Market cap $671.08MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| RTW Investments, LP Joint filing with Roderick Wong (9.90%) | 9,018,724 | 9.90% | 13G (passive) amendment | Mar 31, 2026 |
| Roderick Wong Joint filing with RTW Investments, LP (9.90%) | 7,836,346 | 9.90% | 13G (passive) amendment | Dec 31, 2025 |
| Deep Track Capital, LP Joint filing with Deep Track Biotechnology Master Fund, Ltd. (9.99%), David Kroin (9.99%) | 7,719,390 | 9.99% | 13G (passive) | Nov 14, 2025 |
| Armistice Capital, LLC Joint filing with Steven Boyd (7.76%) | 7,024,000 | 7.76% | 13G (passive) amendment | Jun 30, 2026 |
| BlackRock, Inc. | 6,187,012 | 7.00% | 13G (passive) amendment | Jun 30, 2026 |
| Bam Gp LLC Joint filing with Balyasny Asset Management L.P. (9.99%), Balyasny Asset Management Holdings LP (9.99%) and 2 more | 5,777,396 | 9.99% | 13G (passive) amendment | Jun 30, 2025 |
| Lampert Mark N Joint filing with Bvf Partners L P/Il (9.99%), Bvf Inc/Il (9.99%) and 3 more | 5,720,831 | 9.99% | 13G (passive) amendment | Jun 30, 2025 |
| Dames GP LLC Joint filing with Balyasny Asset Management L.P. (9.29%), Bam Gp LLC (9.29%) and 2 more | 5,718,190 | 9.29% | 13G (passive) amendment | Sep 30, 2025 |
| Daniel Mack Joint filing with Nantahala Capital Management, LLC (9.99%), Wilmot B. Harkey (9.99%) | 5,459,278 | 9.99% | 13G (passive) amendment | Mar 31, 2025 |
| Bvf Partners L P/Il Joint filing with Bvf Inc/Il (9.99%), Lampert Mark N (9.99%) and 3 more | 4,706,551 | 9.99% | 13G (passive) amendment | Dec 31, 2024 |
| Wilmot B. Harkey Joint filing with Nantahala Capital Management, LLC (7.13%), Daniel Mack (7.13%) | 4,626,236 | 7.13% | 13G (passive) amendment | Sep 30, 2025 |
| Roderick Wong, M.D. Joint filing with RTW Investments, LP (8.30%) | 4,245,476 | 8.30% | 13G (passive) | Mar 31, 2025 |
| Ramya Rao | 3,949,801 | 8.87% | 13G (passive) | Dec 31, 2024 |
| Steven Boyd Joint filing with Armistice Capital, LLC (5.30%) | 3,536,000 | 5.30% | 13G (passive) | Dec 31, 2025 |
| Logos GP LLC Joint filing with Logos Global Management LP (6.20%), Logos Global Management GP LLC (6.20%) and 2 more | 3,425,000 | 6.20% | 13G (passive) | Jul 21, 2025 |
| Polar Capital Funds PLC - Biotechnology Fund Joint filing with Polar Capital Holdings Plc (5.09%), Polar Capital LLP (5.09%) | 3,398,899 | 5.09% | 13G (passive) | Dec 31, 2025 |
| Soleus GP LLC Joint filing with Soleus Capital Management, L.P. (7.30%), Guy Levy (7.30%) | 3,350,692 | 7.30% | 13G (passive) amendment | Dec 31, 2024 |
| Tananbaum James B. Joint filing with Foresite Capital Fund VI LP (5.10%), Foresite Capital Management VI, LLC (5.10%) | 3,135,120 | 5.10% | 13G (passive) | Oct 16, 2025 |
| Stonepine Capital Management, LLC Joint filing with Stonepine Capital, L.P. (5.00%), Stonepine GP, LLC (5.00%) and 1 more | 2,833,333 | 5.00% | 13G (passive) | Jul 22, 2025 |
| Vivo Opportunity Fund Holdings, L.P. Joint filing with Vivo Opportunity, LLC (6.10%) | 1,538,461 | 6.10% | 13G (passive) amendment | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of VSTM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9,192,447 | 10.15% | $35.12M | +2,997,522 | 0.00% |
| Nantahala Capital Management, LLC | 7,169,640 | 7.92% | $27.39M | +3,584,820 | 0.46% |
| Armistice Capital, LLC | 7,024,000 | 7.76% | $26.83M | +2,432,000 | 0.33% |
| Rtw Investments, LP | 6,635,793 | 7.33% | $25.35M | +59,487 | 0.22% |
| Deep Track Capital, LP | 5,740,850 | 6.34% | $21.93M | – | 0.32% |
| State Street Corp | 5,133,859 | 5.67% | $19.61M | +1,617,208 | 0.00% |
| Rosalind Advisors, Inc. | 3,986,509 | 4.40% | $15.23M | +1,848,034 | 5.66% |
| Vanguard Capital Management LLC | 3,851,508 | 4.25% | $14.71M | +528,738 | 0.00% |
| Stonepine Capital Management, LLC | 3,349,627 | 3.70% | $12.80M | +47,327 | 7.22% |
| Vanguard Portfolio Management LLC | 3,266,870 | 3.61% | $12.48M | +2,509,995 | 0.00% |
| Foresite Capital Management VI LLC | 3,146,631 | 3.47% | $12.02M | – | 1.87% |
| Goldman Sachs Group Inc | 2,721,178 | 3.00% | $10.39M | +1,237,175 | 0.00% |
| Baker Bros. Advisors LP | 2,499,338 | 2.76% | $9.55M | +1,914,581 | 0.05% |
| Alyeska Investment Group, L.P. | 2,289,625 | 2.53% | $8.75M | +239,625 | 0.02% |
| Millennium Management LLC | 2,078,003 | 2.29% | $7.94M | −333,962 | 0.00% |
| Geode Capital Management, LLC | 2,074,145 | 2.29% | $7.93M | +356,588 | 0.00% |
| AIGH Capital Management LLC | 1,927,000 | 2.13% | $7.36M | −73,000 | 0.46% |
| Opaleye Management Inc. | 1,800,000 | 1.99% | $6.88M | New | 0.62% |
| Balyasny Asset Management L.P. | 1,686,575 | 1.86% | $6.44M | +1,276,796 | 0.01% |
| Qube Research & Technologies Ltd | 1,628,488 | 1.80% | $6.22M | +152,460 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 158 | 99M | 100.0% | 34 / 69 | 37 / 28 | 29M | 11M |
| Q1 2026 | 155 | 81M | 89.9% | 41 / 70 | 26 / 27 | 26M | 17M |
| Q4 2025 | 143 | 77M | 84.5% | 45 / 50 | 31 / 20 | 32M | 15M |
| Q3 2025 | 118 | 60M | 65.9% | 29 / 40 | 36 / 19 | 22M | 15M |
| Q2 2025 | 109 | 53M | 58.5% | 28 / 46 | 21 / 17 | 20M | 10M |
| Q1 2025 | 99 | 43M | 47.8% | 21 / 36 | 24 / 12 | 14M | 5M |
| Q4 2024 | 92 | 35M | 38.3% | 29 / 37 | 11 / 14 | 14M | 6M |
| Q3 2024 | 77 | 27M | 29.4% | 21 / 36 | 7 / 10 | 15M | 2M |
| Q2 2024 | 68 | 15M | 16.5% | 23 / 22 | 12 / 25 | 5M | 7M |
| Q1 2024 | 70 | 17M | 18.8% | 17 / 16 | 18 / 5 | 2M | 2M |
| Q4 2023 | 58 | 17M | 18.6% | 5 / 16 | 12 / 4 | 1M | 1M |
| Q3 2023 | 57 | 17M | 18.5% | 7 / 18 | 17 / 9 | 3M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
122 funds held VSTM in Q2 2026, 67% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of VSTM | Value | % of fund | As of |
|---|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 3,389,113 | 3.74% | $12.95M | 0.12% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 2,811,948 | 3.10% | $10.74M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 2,066,204 | 2.28% | $7.89M | 0.01% | Jun 30, 2026 |
| Vanguard Explorer Fund | 1,397,172 | 1.54% | $8.10M | 0.04% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 960,598 | 1.06% | $3.67M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 872,784 | 0.96% | $5.06M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 750,135 | 0.83% | $2.87M | 0.02% | Jun 30, 2026 |
| BlackRock Advantage Small Cap Core Fund | 701,337 | 0.77% | $3.04M | 0.06% | May 29, 2026 |
| Fidelity Enhanced Small Cap Core ETF | 575,899 | 0.64% | $2.20M | 0.04% | Jun 30, 2026 |
| Vanguard Strategic Small-Cap Equity Fund | 536,651 | 0.59% | $2.05M | 0.07% | Jun 30, 2026 |
| Franklin Biotechnology Discovery Fund | 401,744 | 0.44% | $2.33M | 0.20% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 378,589 | 0.42% | $1.64M | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 343,561 | 0.38% | $1.49M | 0.01% | May 31, 2026 |
| Virtus Biotech Etf | 331,013 | 0.37% | $1.92M | 1.95% | Jul 31, 2026 |
| Small Company Growth Portfolio | 330,409 | 0.36% | $1.26M | 0.07% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Dan Paterson | President and CEO, Director | 844,542 | 0.93% | Nov 5, 2026 |
| Michael Kauffman | President of Development, Director | 8,666 | 0.01% | Jan 8, 2026 |
| Daniel Calkins | Chief Financial Officer | 123,781 | 0.14% | Oct 2, 2026 |
| Matthew Ros | Chief Operating Officer | 50,000 | 0.06% | Apr 3, 2025 |
| Michael P. Bailey | Director | 108,000 | 0.12% | May 27, 2026 |
| Michelle Robertson | Director | 52,666 | 0.06% | May 26, 2026 |
| Paul A. Bunn | Director | 44,333 | 0.05% | May 26, 2026 |
| Karin Anna Tollefson | Director | 52,666 | 0.06% | May 26, 2026 |
| Eric K. Rowinsky | Director | 54,666 | 0.06% | May 26, 2026 |
| John Johnson | Director | 52,666 | 0.06% | May 26, 2026 |
| Brian M. Stuglik | Director | 137,147 | 0.15% | May 26, 2026 |
| Anil Kapur | Director | 52,666 | 0.06% | May 26, 2026 |
| Robert E. Gagnon | Director | 41,678 | 0.05% | Dec 18, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Dan Paterson President and CEO, Director | Nov 3, 2026 | Sale(10b5-1 plan) | −1,299 | $9.60 | $12.47K | 651,413 |
| Dan Paterson President and CEO, Director | Oct 1, 2026 | Sale(10b5-1 plan) | −44,121 | $8.00 | $352.97K | 652,712 |
| Daniel Calkins Chief Financial Officer | Oct 1, 2026 | Sale(10b5-1 plan) | −2,566 | $8.00 | $20.53K | 123,781 |
| Dan Paterson President and CEO, Director | Sep 30, 2026 | Award | −106,893 | – | – | 696,833 |
| Daniel Calkins Chief Financial Officer | Sep 30, 2026 | Award | −8,333 | – | – | 126,347 |
| Daniel Calkins Chief Financial Officer | Sep 21, 2026 | Sale(10b5-1 plan) | −55 | $7.70 | $424 | 118,014 |
| Dan Paterson President and CEO, Director | Aug 3, 2026 | Sale(10b5-1 plan) | −1,302 | $5.81 | $7.56K | 589,940 |
| Dan Paterson President and CEO, Director | Jun 22, 2026 | Sale(10b5-1 plan) | −20,871 | $4.18 | $87.24K | 591,242 |
| Daniel Calkins Chief Financial Officer | Jun 22, 2026 | Sale(10b5-1 plan) | −57 | $4.13 | $235 | 117,238 |
| Daniel Calkins Chief Financial Officer | Jun 22, 2026 | Sale(10b5-1 plan) | −4,032 | $4.18 | $16.85K | 117,295 |
| Michael P. Bailey Director | May 21, 2026 | Award | +108,000 | – | – | 108,000 |
| Paul A. Bunn Director | May 21, 2026 | Award | +36,000 | – | – | 44,333 |
| Karin Anna Tollefson Director | May 21, 2026 | Award | +36,000 | – | – | 52,666 |
| Anil Kapur Director | May 21, 2026 | Award | +36,000 | – | – | 52,666 |
| Eric K. Rowinsky Director | May 21, 2026 | Award | +36,000 | – | – | 52,666 |
| John Johnson Director | May 21, 2026 | Award | +36,000 | – | – | 52,666 |
| Michelle Robertson Director | May 21, 2026 | Award | +36,000 | – | – | 52,666 |
| Brian M. Stuglik Director | May 21, 2026 | Award | +36,000 | – | – | 137,147 |
| Dan Paterson President and CEO, Director | May 4, 2026 | Sale(10b5-1 plan) | −806 | $5.82 | $4.69K | 612,113 |
| Daniel Calkins Chief Financial Officer | Mar 20, 2026 | Award | −57 | $5.74 | $327 | 121,327 |
| Dan Paterson President and CEO, Director | Feb 4, 2026 | Sale(10b5-1 plan) | −970 | $6.69 | $6.49K | 612,919 |
| Dan Paterson President and CEO, Director | Jan 21, 2026 | Award | +213,785 | – | – | 613,889 |
| Daniel Calkins Chief Financial Officer | Jan 21, 2026 | Award | +16,665 | – | – | 121,384 |
| Daniel Calkins Chief Financial Officer | Jan 12, 2026 | Sale(10b5-1 plan) | −5,039 | $7.16 | $36.08K | 104,719 |
| Dan Paterson President and CEO, Director | Jan 12, 2026 | Sale(10b5-1 plan) | −10,321 | $7.16 | $73.90K | 400,104 |
| Daniel Calkins Chief Financial Officer | Dec 24, 2025 | Sale(10b5-1 plan) | −80 | $7.86 | $629 | 109,758 |
| Brian M. Stuglik Director | Dec 16, 2025 | Sale(10b5-1 plan) | −592 | $9.14 | $5.41K | 101,147 |
| Dan Paterson President and CEO, Director | Dec 16, 2025 | Sale(10b5-1 plan) | −393 | $9.14 | $3.59K | 410,425 |
| Robert E. Gagnon Director | Dec 16, 2025 | Sale(10b5-1 plan) | −283 | $9.14 | $2.59K | 41,678 |
| Dan Paterson President and CEO, Director | Dec 11, 2025 | Sale(10b5-1 plan) | −2,000 | $10.00 | $20.00K | 410,818 |
| Dan Paterson President and CEO, Director | Dec 10, 2025 | Sale(10b5-1 plan) | −2,000 | $10.07 | $20.14K | 412,818 |
| Dan Paterson President and CEO, Director | Dec 9, 2025 | Sale(10b5-1 plan) | −2,000 | $10.25 | $20.50K | 414,818 |
| Dan Paterson President and CEO, Director | Dec 8, 2025 | Sale(10b5-1 plan) | −2,000 | $10.50 | $21.00K | 416,818 |
| Dan Paterson President and CEO, Director | Dec 5, 2025 | Sale(10b5-1 plan) | −2,000 | $10.61 | $21.22K | 418,818 |
| Dan Paterson President and CEO, Director | Dec 4, 2025 | Sale(10b5-1 plan) | −2,000 | $10.00 | $20.00K | 420,818 |
| Dan Paterson President and CEO, Director | Dec 3, 2025 | Sale(10b5-1 plan) | −2,000 | $10.00 | $20.00K | 422,818 |
| Dan Paterson President and CEO, Director | Dec 2, 2025 | Sale(10b5-1 plan) | −2,000 | $10.32 | $20.64K | 424,818 |
| Dan Paterson President and CEO, Director | Dec 1, 2025 | Sale(10b5-1 plan) | −2,000 | $10.39 | $20.78K | 426,818 |
| Dan Paterson President and CEO, Director | Nov 28, 2025 | Sale(10b5-1 plan) | −2,000 | $10.79 | $21.58K | 428,818 |
| Dan Paterson President and CEO, Director | Nov 26, 2025 | Sale(10b5-1 plan) | −2,000 | $10.32 | $20.64K | 430,818 |
| Dan Paterson President and CEO, Director | Nov 25, 2025 | Sale(10b5-1 plan) | −2,000 | $10.00 | $20.00K | 432,818 |
| Dan Paterson President and CEO, Director | Nov 24, 2025 | Sale(10b5-1 plan) | −2,000 | $10.00 | $20.00K | 434,818 |
| Dan Paterson President and CEO, Director | Nov 21, 2025 | Sale(10b5-1 plan) | −2,000 | $10.00 | $20.00K | 436,818 |
| Michael Kauffman Director | Nov 21, 2025 | Sale(10b5-1 plan) | −8,550 | $10.00 | $85.50K | 8,666 |
| Paul A. Bunn Director | Nov 21, 2025 | Option exercise | +6,250 | $3.27 | $20.44K | 8,333 |
| Paul A. Bunn Director | Nov 21, 2025 | Sale(10b5-1 plan) | −6,250 | $10.00 | $62.50K | 2,083 |
| Dan Paterson President and CEO, Director | Nov 3, 2025 | Sale(10b5-1 plan) | −2,000 | $10.00 | $20.00K | 438,818 |
| Dan Paterson President and CEO, Director | Nov 3, 2025 | Sale(10b5-1 plan) | −1,299 | $9.35 | $12.15K | 440,818 |
| Paul A. Bunn Director | Oct 9, 2025 | Sale(10b5-1 plan) | −8,333 | $9.06 | $75.50K | 8,333 |
| Daniel Calkins Chief Financial Officer | Sep 24, 2025 | Sale(10b5-1 plan) | −25 | $9.23 | $231 | 109,838 |
| Daniel Calkins Chief Financial Officer | Sep 22, 2025 | Sale(10b5-1 plan) | −57 | $9.08 | $518 | 109,863 |
| Dan Paterson President and CEO, Director | Sep 16, 2025 | Sale(10b5-1 plan) | −390 | $9.99 | $3.90K | 442,117 |
| Brian M. Stuglik Director | Sep 16, 2025 | Sale(10b5-1 plan) | −587 | $9.99 | $5.86K | 101,739 |
| Robert E. Gagnon Director | Sep 16, 2025 | Sale(10b5-1 plan) | −281 | $9.99 | $2.81K | 41,961 |
| Dan Paterson President and CEO, Director | Aug 6, 2025 | Sale(10b5-1 plan) | −1,332 | $5.81 | $7.74K | 442,507 |
| Daniel Calkins Chief Financial Officer | Jun 23, 2025 | Sale(10b5-1 plan) | −25 | $4.71 | $118 | 109,920 |
| Dan Paterson President and CEO, Director | Jun 20, 2025 | Sale(10b5-1 plan) | −17,808 | $5.13 | $91.36K | 443,839 |
| Daniel Calkins Chief Financial Officer | Jun 20, 2025 | Sale(10b5-1 plan) | −4,110 | $5.13 | $21.08K | 109,945 |
| Dan Paterson President and CEO, Director | Jun 16, 2025 | Sale | −335 | $5.65 | $1.89K | 461,647 |
| Brian M. Stuglik Director | Jun 16, 2025 | Sale | −594 | $5.65 | $3.36K | 102,326 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Verastem's stock actually held short. Settlement fails (shares not delivered on time) peaked at 216,889 shares on Oct 8, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Dan Paterson Officer, Director | Oct 1, 2026 | 44,121 | $353.05K | Oct 1, 2026 | Vesting of restricted stock unit award |
| Robert E. Gagnon Director | Jul 23, 2026 | 31,924 | $188.03K | Jul 23, 2026 | Vested Restricted Stock Units |
| Robert E. Gagnon Director | Jun 25, 2026 | 21,492 | $90.48K | Jun 25, 2026 | Vested Restricted Stock Units |
| Dan Paterson Officer, Director | Jun 22, 2026 | 20,871 | $87.24K | Jun 22, 2026 | Vesting of restricted stock unit award |
| Robert E. Gagnon Director | May 27, 2026 | 20,103 | $87.65K | May 27, 2026 | Vested Restricted Stock Units |
| Dan Paterson Officer | Jan 14, 2026 | 5,039 | $36.07K | Jan 12, 2026 | Vesting of restricted stock unit award |
| Dan Paterson Officer, Director | Jan 14, 2026 | 10,321 | $73.85K | Jan 12, 2026 | Vesting of restricted stock unit award |
| Dan Paterson Officer | Dec 10, 2025 | 11,790 | $117.90K | Dec 5, 2025 | Acquired as compensation - RSU |
| Dan Paterson Officer | Dec 9, 2025 | 7,790 | $80.00K | Dec 9, 2025 | Acquired as compensation |
| Paul A. Bunn Board Member | Nov 21, 2025 | 6,250 | $61.31K | Nov 21, 2025 | Stock Option Grant |
| Michael Kauffman Board Member | Nov 21, 2025 | 8,550 | $83.88K | Nov 21, 2025 | Restricted Stock Grant |
| Paul A. Bunn Board Member | Oct 9, 2025 | 8,333 | $74.50K | Oct 9, 2025 | Restricted Stock Grant |
| Dan Paterson Officer, Director | Sep 4, 2025 | 31,790 | $310.43K | Sep 17, 2025 | Acquired as Compensation - RSUs |
| Dan Paterson Officer, Director | Jun 20, 2025 | 17,808 | $91.33K | Jun 20, 2025 | Vesting of restricted stock unit award |
| Dan Paterson Officer, Director | May 20, 2025 | 58,677 | $477.04K | May 20, 2025 | Vesting of restricted stock unit award |
See a number that looks wrong?